ArticleFrontiers in microbiology2026
TPT: a compact CNN-transformer encoder for efficient microbial small protein modeling.
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Microbial small proteins, encoded by small open reading frames (smORFs), play essential roles in antimicrobial activity, metabolic regulation, and signaling pathways. However, their short length and rapid evolutionary rate present significant challenges for computational modeling. Methods: We introduce TinyProteinTransformer (TPT), a lightweight CNN-Transformer hybrid encoder pretrained on the Global Microbial smORF Catalog (GMSC; >280 million smORF families). TPT integrates multi-scale convolutional filters to capture local sequence motifs with Transformer layers for broader contextual modeling, and is trained jointly with masked language modeling and contrastive learning to capture both residue-level and sequence-level representations. We evaluated TPT on six downstream peptide/protein classification benchmarks spanning antimicrobial peptides (AMP), toxic peptides (TOX), bacteriocins (BCN), anti-CRISPR proteins (Acr), quorum-sensing peptides (QSP), and cell-penetrating peptides (CPP) using frozen-encoder linear probing. Results: On the AMP and TOX tasks, TPT (103 M parameters) matched ESM2-150 M in predictive performance (AUC 0.930 vs. 0.928 for AMP; 0.930 vs. 0.925 for TOX) while achieving 4.3-fold faster inference. Across the evaluated benchmarks, TPT showed competitive performance compared with larger protein language models. Ablation experiments identified the contrastive objective as an important contributor to representation quality: its removal reduced AUC across all six downstream tasks and produced performance patterns consistent with MLM-only pretraining. Conclusion: These results suggest that, within the evaluated benchmarks, effective smORF representation may benefit from pretraining objectives and inductive biases tailored to short, rapidly evolving sequences, rather than from model scale alone. TPT therefore provides a compact and computationally efficient encoder with competitive performance for microbial peptide analysis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.